Nikolay V. Ilyin
Nikolay V. Ilyin has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Juliya Nikolaevna Vinogradova
Russian Scientific Centre of Radiology and Surgical Technologies named after Academician A.M. Granov of the Ministry of Health of Russia
13 shared publications - Maria I. Zelianina
Granov Russian Research Center of Radiology and Surgical Technologies
5 shared publications - Denis Vladimirovich Zaslavsky
Saint-Petersburg State Pediatric Medical University
4 shared publications - Artem V. Kartashev
A.M. Granov Russian Research Center of Radiology and Surgical Technologies
3 shared publications - Elina V. Gilvanova
Granov Russian Research Center of Radiology and Surgical Technologies
3 shared publications - M. S. Tlostanova
A.M. Granov Russian Research Center of Radiology and Surgical Technologies
3 shared publications
Latest Publications
- 14 June 2026
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 9 (2)
Pseudolesions of the Liver According to PET/CT with 18F-FDG and Other Imaging Techniques for Hodgkin’s Lymphoma
In most cases, the detection of focal liver changes in patients with systemic lymphoproliferative disease by imaging methods is associated in the mind of a radiologist with organ damage, which, accordingly, significantly affects the determination of the stage and treatment strategy. The PET/CT method is recognized as the most informative in determining the prevalence of the pathological process in Hodgkin’s lymphoma [1]. When determining the nature of focal changes in the liver parenchyma, the diagnostician is faced with the need to differentiate organ damage by a systemic process from pseudolesions. The picture of these processes in ultrasound (ultrasound), computed tomography (CT), and magnetic resonance imaging (MRI) has been studied for a long time, and data on the capabilities of PET/CT in combination with other imaging methods have not been sufficiently studied. Purpose. To introduce colleagues to a special type of selective accumulation of 18 F-FDG in the liver, a trap that can become a source of misinterpretation and compare PET data with other imaging methods.
- 14 June 2026
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 9 (2)
Pseudolesions of the Liver According to PET/CT with 18F-FDG and Other Imaging Techniques for Hodgkin’s Lymphoma
In most cases, the detection of focal liver changes in patients with systemic lymphoproliferative disease by imaging methods is associated in the mind of a radiologist with organ damage, which, accordingly, significantly affects the determination of the stage and treatment strategy. The PET/CT method is recognized as the most informative in determining the prevalence of the pathological process in Hodgkin’s lymphoma [1]. When determining the nature of focal changes in the liver parenchyma, the diagnostician is faced with the need to differentiate organ damage by a systemic process from pseudolesions. The picture of these processes in ultrasound (ultrasound), computed tomography (CT), and magnetic resonance imaging (MRI) has been studied for a long time, and data on the capabilities of PET/CT in combination with other imaging methods have not been sufficiently studied. Purpose. To introduce colleagues to a special type of selective accumulation of 18 F-FDG in the liver, a trap that can become a source of misinterpretation and compare PET data with other imaging methods.
- Open Access
- 22 September 2025
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 28 (4) , 381-390
Dermatoscopic methods for diagnosing radiation-induced skin reactions in patients with primary cutaneous lymphomas undergoing total skin electron beam therapy
Background: Timely diagnosis and assessment of radiation-induced skin reactions remain an important challenge in modern medicine. Imaging techniques can help standardize the clinical evaluation of radiation dermatitis. Aim: The work aimed to evaluate dermatoscopic features and confocal microscopy findings in radiation dermatitis among patients with primary cutaneous lymphomas undergoing radiotherapy, with subsequent analysis of the clinical and morphological characteristics of affected skin areas before treatment and at cumulative doses of 6 Gy, 14 Gy, and 30 Gy, based on macroscopic and dermatoscopic imaging of radiation-induced skin reactions for further comparison. Methods: Data from 40 patients at the Granov Russian Scientific Center for Radiology and Surgical Technologies receiving electron beam radiotherapy for primary cutaneous lymphomas were analyzed. As clinical symptoms of radiation-induced skin reactions developed, morphological changes in the affected areas were examined. Dermatoscopic evaluation of skin lesions was performed using a HYPERLINK "https://shop.heine-med.ru/catalog/dermatoskopy/?ysclid=m63jpoace3558532091"Heine Optotechnik (Germany) dermatoscope at tenfold magnification. Confocal spectroscopy was conducted using the VivaScope® 1500 medical device (MAVIG GmbH, Munich, Germany). Instrumental data underwent correlation analysis to identify statistical relationships between dermatoscopic parameters and the severity of radiation-induced skin reactions. Results: Dermatoscopy revealed patterns characteristic of different stages of radiation-induced skin reactions: reticular vascular arrangements in the dermis, brown scaly elements, perifollicular pigmentation, and follicular plugs arranged in rosette-like patterns. Confocal microscopy of radiation dermatitis lesions identified non-stochastic skin changes, including exocytosis (55.3%), spongiosis (63.5%), disorganization of the epidermis (65%), and abnormally structured dermal papillae (85.4%). Low-contrast microvascular cells marking vascular dysfunction in the dermal vascular bed were a specific feature of radiation dermatitis observed regardless of severity. Conclusion: Accurate assessment of skin damage severity can help optimize the management of patients undergoing radiotherapy for primary cutaneous lymphomas. These findings are promising for integrating instrumental evaluation methods into routine clinical practice for early detection of radiation-induced skin changes and predicting disease severity.
- 22 September 2025
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 28 (4) , 381-390
Open AccessDermatoscopic methods for diagnosing radiation-induced skin reactions in patients with primary cutaneous lymphomas undergoing total skin electron beam therapy
Background: Timely diagnosis and assessment of radiation-induced skin reactions remain an important challenge in modern medicine. Imaging techniques can help standardize the clinical evaluation of radiation dermatitis. Aim: The work aimed to evaluate dermatoscopic features and confocal microscopy findings in radiation dermatitis among patients with primary cutaneous lymphomas undergoing radiotherapy, with subsequent analysis of the clinical and morphological characteristics of affected skin areas before treatment and at cumulative doses of 6 Gy, 14 Gy, and 30 Gy, based on macroscopic and dermatoscopic imaging of radiation-induced skin reactions for further comparison. Methods: Data from 40 patients at the Granov Russian Scientific Center for Radiology and Surgical Technologies receiving electron beam radiotherapy for primary cutaneous lymphomas were analyzed. As clinical symptoms of radiation-induced skin reactions developed, morphological changes in the affected areas were examined. Dermatoscopic evaluation of skin lesions was performed using a HYPERLINK "https://shop.heine-med.ru/catalog/dermatoskopy/?ysclid=m63jpoace3558532091"Heine Optotechnik (Germany) dermatoscope at tenfold magnification. Confocal spectroscopy was conducted using the VivaScope® 1500 medical device (MAVIG GmbH, Munich, Germany). Instrumental data underwent correlation analysis to identify statistical relationships between dermatoscopic parameters and the severity of radiation-induced skin reactions. Results: Dermatoscopy revealed patterns characteristic of different stages of radiation-induced skin reactions: reticular vascular arrangements in the dermis, brown scaly elements, perifollicular pigmentation, and follicular plugs arranged in rosette-like patterns. Confocal microscopy of radiation dermatitis lesions identified non-stochastic skin changes, including exocytosis (55.3%), spongiosis (63.5%), disorganization of the epidermis (65%), and abnormally structured dermal papillae (85.4%). Low-contrast microvascular cells marking vascular dysfunction in the dermal vascular bed were a specific feature of radiation dermatitis observed regardless of severity. Conclusion: Accurate assessment of skin damage severity can help optimize the management of patients undergoing radiotherapy for primary cutaneous lymphomas. These findings are promising for integrating instrumental evaluation methods into routine clinical practice for early detection of radiation-induced skin changes and predicting disease severity.
- Open Access
- 2 April 2025
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 8 (1) , 9-18
Total Skin Irradiation in the Treatment of Primary Cutaneous Lymphomas: a Literature Review and Clinical Cases
Introduction: Primary cutaneous lymphomas represent a heterogeneous group of diseases, the treatment of advanced stages of which requires a comprehensive approach, including systemic therapy and skin-directed methods. Total skin electron irradiation (TSEB) demonstrates high efficacy due to the radiosensitivity of lymphoid cells. Despite the high overall response rate, the recommended dose ranges and fractionation schemes for TSEB vary, necessitating detailed investigation. Stratification of patients by clinical stage, type of lesions, and the extent of skin involvement is crucial for optimizing TSEB, improving outcomes, and reducing side effects.Total skin electron beam radiotherapy: A Trend Toward Low Doses: TSEB with cumulative doses of 30ʹ36 Gy has established itself as an effective treatment method; however, there is growing interest in lower doses (10ʹ29 Gy) due to the high radiosensitivity of lymphomas and the need to reduce radiation-related side effects. Studies have confirmed a high overall response to low doses, especially in early stages, with less pronounced radiation reactions and a comparable median duration of response. To optimize the approach, further research is needed, including the development of patient selection criteria and dose individualization with a potential boost to large lesions.Conclusions: The question of the optimal cumulative dose for TSEB in patients with primary cutaneous lymphomas remains insufficiently studied. Clinical cases confirm the efficacy of both standard doses (30ʹ36 Gy) and low doses (10ʹ20 Gy), demonstrating good clinical responses, symptom reduction, and lower toxicity. Low dose TSEB provides a comparable overall response to standard doses, reduces the number of treatment visits, and enables retreatment in case of disease relapse. The main tasks remain to study the factors influencing dose selection (disease stage, type of lesions, individual patient characteristics) and to develop patient management strategies. TSEB effectively controls disease manifestations even in complex cases. Data analysis highlights the need for unified patient selection criteria and optimization of irradiation techniques to improve outcomes and reduce treatment toxicity.
- 2 April 2025
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 8 (1) , 9-18
Open AccessTotal Skin Irradiation in the Treatment of Primary Cutaneous Lymphomas: a Literature Review and Clinical Cases
Introduction: Primary cutaneous lymphomas represent a heterogeneous group of diseases, the treatment of advanced stages of which requires a comprehensive approach, including systemic therapy and skin-directed methods. Total skin electron irradiation (TSEB) demonstrates high efficacy due to the radiosensitivity of lymphoid cells. Despite the high overall response rate, the recommended dose ranges and fractionation schemes for TSEB vary, necessitating detailed investigation. Stratification of patients by clinical stage, type of lesions, and the extent of skin involvement is crucial for optimizing TSEB, improving outcomes, and reducing side effects.Total skin electron beam radiotherapy: A Trend Toward Low Doses: TSEB with cumulative doses of 30ʹ36 Gy has established itself as an effective treatment method; however, there is growing interest in lower doses (10ʹ29 Gy) due to the high radiosensitivity of lymphomas and the need to reduce radiation-related side effects. Studies have confirmed a high overall response to low doses, especially in early stages, with less pronounced radiation reactions and a comparable median duration of response. To optimize the approach, further research is needed, including the development of patient selection criteria and dose individualization with a potential boost to large lesions.Conclusions: The question of the optimal cumulative dose for TSEB in patients with primary cutaneous lymphomas remains insufficiently studied. Clinical cases confirm the efficacy of both standard doses (30ʹ36 Gy) and low doses (10ʹ20 Gy), demonstrating good clinical responses, symptom reduction, and lower toxicity. Low dose TSEB provides a comparable overall response to standard doses, reduces the number of treatment visits, and enables retreatment in case of disease relapse. The main tasks remain to study the factors influencing dose selection (disease stage, type of lesions, individual patient characteristics) and to develop patient management strategies. TSEB effectively controls disease manifestations even in complex cases. Data analysis highlights the need for unified patient selection criteria and optimization of irradiation techniques to improve outcomes and reduce treatment toxicity.
- Open Access
- 11 November 2024
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 26 (3) , 317-322
Increasing the effectiveness of total-skin electron beam therapy by reducing the manifestations of radiation dermatitis in patients with primary lymphomas. A comparative randomized prospective study
Background. One of the main adverse events that significantly reduce the quality of life of patients and limit the total focal dose is radiation-induced skin reactions (RISR). Their timely diagnosis, prevention, and treatment remain urgent tasks of modern radiotherapy. Aim. To improve the effectiveness of total skin irradiation (TSI) in patients with primary skin lymphomas by reducing the clinical manifestations of RISR by using additional therapy with a hydrogel containing active components with vasoprotective and anti-inflammatory action. Materials and methods. A comparative randomized prospective study was conducted, including data from 52 patients who received electron TSI by conventional fractionation at a total focal dose of 14 to 30 Gy for primary cutaneous lymphomas at the Granov Russian Research Center of Radiology and Surgical Technologies from September 2021 to January 2024. Before the first TSI session, during treatment and 2 weeks after the end of radiation therapy, all patients underwent assessment for RISR, quantitative assessment of various degrees of severity of radiodermatitis using instrumental methods and assessment scales; for the observation group, a therapeutic regimen for the prevention and treatment of RISR was used, including a hydrogel with troxerutin (2%) and trolamine (0.07%), and in the control group, basic skin care using moisturizers. Results. Analysis of the physiological parameters of the skin showed statistically significant differences between the study groups: patients of the study group (group I; 30 subjects receiving the above-mentioned therapeutic regimen) compared with the control group (group II; 28 subjects who did not receive specific treatment for radiodermatitis) reported significantly lower rates of erythema (386±12.3 and 572±14.4; p=0.005), transepidermal water loss (25±0.3 and 38±0.4 g/m2/h; p0.001) and a decrease in peak endothelial-dependent vasodilation of microvasculature and blood flow in the skin. A lower proportion of severe radiodermatitis (86.3 and 73.3%; p0.05) and a statistically significant difference in the subjective quality of life scores by the 29-point Skindex-29 scale by an average of 22.2% were also found. Conclusion. A comparative analysis of the quantitative indicators of radiodermatitis in the study group and the control group showed that the topical application of the hydrocolloid gel containing troxerutin and trolamine reduces the clinical manifestations of RISR concerning objectively measured physiological parameters of the skin and blood flow parameters of the microvasculature measured by high-frequency ultrasound, thus improving the quality of life of patients during and after the course of radiation therapy.
- 11 November 2024
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 26 (3) , 317-322
Open AccessIncreasing the effectiveness of total-skin electron beam therapy by reducing the manifestations of radiation dermatitis in patients with primary lymphomas. A comparative randomized prospective study
Background. One of the main adverse events that significantly reduce the quality of life of patients and limit the total focal dose is radiation-induced skin reactions (RISR). Their timely diagnosis, prevention, and treatment remain urgent tasks of modern radiotherapy. Aim. To improve the effectiveness of total skin irradiation (TSI) in patients with primary skin lymphomas by reducing the clinical manifestations of RISR by using additional therapy with a hydrogel containing active components with vasoprotective and anti-inflammatory action. Materials and methods. A comparative randomized prospective study was conducted, including data from 52 patients who received electron TSI by conventional fractionation at a total focal dose of 14 to 30 Gy for primary cutaneous lymphomas at the Granov Russian Research Center of Radiology and Surgical Technologies from September 2021 to January 2024. Before the first TSI session, during treatment and 2 weeks after the end of radiation therapy, all patients underwent assessment for RISR, quantitative assessment of various degrees of severity of radiodermatitis using instrumental methods and assessment scales; for the observation group, a therapeutic regimen for the prevention and treatment of RISR was used, including a hydrogel with troxerutin (2%) and trolamine (0.07%), and in the control group, basic skin care using moisturizers. Results. Analysis of the physiological parameters of the skin showed statistically significant differences between the study groups: patients of the study group (group I; 30 subjects receiving the above-mentioned therapeutic regimen) compared with the control group (group II; 28 subjects who did not receive specific treatment for radiodermatitis) reported significantly lower rates of erythema (386±12.3 and 572±14.4; p=0.005), transepidermal water loss (25±0.3 and 38±0.4 g/m2/h; p0.001) and a decrease in peak endothelial-dependent vasodilation of microvasculature and blood flow in the skin. A lower proportion of severe radiodermatitis (86.3 and 73.3%; p0.05) and a statistically significant difference in the subjective quality of life scores by the 29-point Skindex-29 scale by an average of 22.2% were also found. Conclusion. A comparative analysis of the quantitative indicators of radiodermatitis in the study group and the control group showed that the topical application of the hydrocolloid gel containing troxerutin and trolamine reduces the clinical manifestations of RISR concerning objectively measured physiological parameters of the skin and blood flow parameters of the microvasculature measured by high-frequency ultrasound, thus improving the quality of life of patients during and after the course of radiation therapy.
- Open Access
- 10 August 2023
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (2) , 185-189
Radiation induced skin reactions in primary cutaneous lymphoma patients: A review
This review highlights the issue of radiation-induced skin reactions (RISR), emphasizes the high frequency of RISR in patients with cutaneous lymphomas undergoing radiation therapy, and analyzes numerous pathological processes that occur in the skin as a result of ionizing radiation exposure. The review systematically examines external and internal factors influencing the development of RISR, compares diagnostic methods, discusses preventive measures and treatments for radiation dermatitis, and describes the mechanisms of action for drugs used in RISR prophylaxis and treatment. RISR remains a significant problem in radiation therapy, characterized by a high frequency, a wide range of clinical manifestations, and an impact on patients quality of life. The mechanisms, diagnosis, prevention, and treatment of RISR are considered.
- 10 August 2023
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (2) , 185-189
Open AccessRadiation induced skin reactions in primary cutaneous lymphoma patients: A review
This review highlights the issue of radiation-induced skin reactions (RISR), emphasizes the high frequency of RISR in patients with cutaneous lymphomas undergoing radiation therapy, and analyzes numerous pathological processes that occur in the skin as a result of ionizing radiation exposure. The review systematically examines external and internal factors influencing the development of RISR, compares diagnostic methods, discusses preventive measures and treatments for radiation dermatitis, and describes the mechanisms of action for drugs used in RISR prophylaxis and treatment. RISR remains a significant problem in radiation therapy, characterized by a high frequency, a wide range of clinical manifestations, and an impact on patients quality of life. The mechanisms, diagnosis, prevention, and treatment of RISR are considered.
- Open Access
- 18 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 95-101
Predictors of radiation-induced skin reactions in patients with T-cell skin lymphomas after total skin irradiation: retrospective cohort study
INTRODUCTION: Skin reactions negatively affect a patient’s quality of life and may require radiation therapy premature interruption, what impairs illness control. Numerous agents determine tissue radiosensitivity, but demographic and lifestyle factors remain poorly understood. Those kind of patients herapeutic algorithm demands studies.OBJECTIVE: Radiation-induced skin reactions (RISR) formation and severity prognostic factors determination for primary malignant skin lymphomas patients.MATERIALS AND METHODS: 45 patients malignant T-cell skin lymphoma study, aged 38 to 82 years (29 mycosis fungoides patients, 2 lymphomatoid papulosis, 14 patients with primary anaplastic large cell skin lymphoma) received fast electrons total skin irradiation on the basis of the Federal State Institution «Russian Radiology and Surgical Technologies Scientific Center named after Academician A.M.Granov» of the Ministry of Health of the Russian Federation from 2012 to June 2022. Radiation therapy performed in the usual fractionation mode on linear electron accelerators Elekta Precise with 4–6 MeV bremsstrahlung total doses from 14 to 30 Gy (22±2.4 Gy). In order to identify the role of possible prognostic factors of skin toxicity — gender, age, body mass index (BMI), smoking status, lymphoma body surface area (BSA), the presence of concomitant diseases (diabetes mellitus and arterial hypertension) and previous chemotherapy.Statistics: Statistical analysis was performed using the IBM SPSS Statistics v. 26 program (developed by IBM Corporation). The value of pRESULTS: The analysis revealed positive associations between the severity of RISR and predictor factors: BMI (r=0.799, pCONCLUSION: Formation and severity prognostic factors for the RCC upon fast electrons total skin exposure for patients with primary malignant T-cell skin lymphomas (mycosis fungoides, lymphomatoid papulosis, primary anaplastic large cell lymphoma of the skin) were identified.
- 18 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 95-101
Open AccessPredictors of radiation-induced skin reactions in patients with T-cell skin lymphomas after total skin irradiation: retrospective cohort study
INTRODUCTION: Skin reactions negatively affect a patient’s quality of life and may require radiation therapy premature interruption, what impairs illness control. Numerous agents determine tissue radiosensitivity, but demographic and lifestyle factors remain poorly understood. Those kind of patients herapeutic algorithm demands studies.OBJECTIVE: Radiation-induced skin reactions (RISR) formation and severity prognostic factors determination for primary malignant skin lymphomas patients.MATERIALS AND METHODS: 45 patients malignant T-cell skin lymphoma study, aged 38 to 82 years (29 mycosis fungoides patients, 2 lymphomatoid papulosis, 14 patients with primary anaplastic large cell skin lymphoma) received fast electrons total skin irradiation on the basis of the Federal State Institution «Russian Radiology and Surgical Technologies Scientific Center named after Academician A.M.Granov» of the Ministry of Health of the Russian Federation from 2012 to June 2022. Radiation therapy performed in the usual fractionation mode on linear electron accelerators Elekta Precise with 4–6 MeV bremsstrahlung total doses from 14 to 30 Gy (22±2.4 Gy). In order to identify the role of possible prognostic factors of skin toxicity — gender, age, body mass index (BMI), smoking status, lymphoma body surface area (BSA), the presence of concomitant diseases (diabetes mellitus and arterial hypertension) and previous chemotherapy.Statistics: Statistical analysis was performed using the IBM SPSS Statistics v. 26 program (developed by IBM Corporation). The value of pRESULTS: The analysis revealed positive associations between the severity of RISR and predictor factors: BMI (r=0.799, pCONCLUSION: Formation and severity prognostic factors for the RCC upon fast electrons total skin exposure for patients with primary malignant T-cell skin lymphomas (mycosis fungoides, lymphomatoid papulosis, primary anaplastic large cell lymphoma of the skin) were identified.
- Open Access
- 18 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 102-108
Possibilities of using navigational transcranial magnetic stimulation as an element of radiotherapy preparation of patients with brain tumors: a pilot study
INTRODUCTION: Navigational transcranial magnetic stimulation (NTMs) is used in neurosurgical practice to identify functionally important motor areas of the brain for the purpose of safe resection of a tumor focus. At the same time, when planning radiation therapy (LT) and determining the amount of irradiation, until recently, functionally significant zones of topical representation of skeletal muscles in the cerebral cortex were not taken into account. This study evaluates the use of mapping motor areas of the cerebral cortex using NTMs when planning LT in patients with malignant gliomas affecting the motor cortex.OBJECTIVE: To evaluate the possibilities of navigational transcranial magnetic stimulation in the pre-radiation preparation of patients with brain tumors.MATERIALS AND METHODS: The study included 31 patients with gliomas of a high degree of malignancy who received radiation and/or chemoradiotherapy at the RSCRT from 2020 to 2022. The median follow-up was 12.1 months (3.0–24.5 months), while all patients were followed up to the control, 3-month follow-up period after the end of the course of radiation therapy, 23 patients showed up for control after 6 months (two patients died between 3-month and 6-month control).Statistics: analysis was performed using the Statistica 10.0 software (StatSoft, Inc., USA).RESULTS: Three out of 31 patients had improved motor function, while eight out of 31 patients had decreased motor function. Moreover, when comparing the preoperative condition with the condition during control examinations six months after radiation therapy, motor function improved in three patients, and decreased in eight. Maps of motor zones of NTMs overlapped PTV by 41.2%. The average dose of Dmean maps of NTMs was 42.3 Gy (3.7–61.1 Gy) and 37.0 Gy (3.6–55.8 Gy) with a limit of 45 Gy per motor zone. Thus, the average dose of Dmean according to the maps of the motor zones of NTMs was significantly reduced by 5.3±3.3 Gy (14.3%, pDISCUSSION: In our study, it was shown that maps of the motor zones of NTMs can be used in the planning of LT patients with gliomas of high malignancy. To date, the primary motor cortex has not been considered as an OR in such patients. The results of the study demonstrated that the dose in relation to the maps of the motor zones of NTMs can be significantly reduced without affecting the therapeutic doses for PTV.CONCLUSION: LT planning using NTMs motor maps can help reduce the radiation dose to the motor cortex in primary LT, although the motor cortex appears morphologically rather insensitive to LT compared to speech zones and areas of high-order cognitive processes, such as the temporal and limbic cortex.
- 18 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 102-108
Open AccessPossibilities of using navigational transcranial magnetic stimulation as an element of radiotherapy preparation of patients with brain tumors: a pilot study
INTRODUCTION: Navigational transcranial magnetic stimulation (NTMs) is used in neurosurgical practice to identify functionally important motor areas of the brain for the purpose of safe resection of a tumor focus. At the same time, when planning radiation therapy (LT) and determining the amount of irradiation, until recently, functionally significant zones of topical representation of skeletal muscles in the cerebral cortex were not taken into account. This study evaluates the use of mapping motor areas of the cerebral cortex using NTMs when planning LT in patients with malignant gliomas affecting the motor cortex.OBJECTIVE: To evaluate the possibilities of navigational transcranial magnetic stimulation in the pre-radiation preparation of patients with brain tumors.MATERIALS AND METHODS: The study included 31 patients with gliomas of a high degree of malignancy who received radiation and/or chemoradiotherapy at the RSCRT from 2020 to 2022. The median follow-up was 12.1 months (3.0–24.5 months), while all patients were followed up to the control, 3-month follow-up period after the end of the course of radiation therapy, 23 patients showed up for control after 6 months (two patients died between 3-month and 6-month control).Statistics: analysis was performed using the Statistica 10.0 software (StatSoft, Inc., USA).RESULTS: Three out of 31 patients had improved motor function, while eight out of 31 patients had decreased motor function. Moreover, when comparing the preoperative condition with the condition during control examinations six months after radiation therapy, motor function improved in three patients, and decreased in eight. Maps of motor zones of NTMs overlapped PTV by 41.2%. The average dose of Dmean maps of NTMs was 42.3 Gy (3.7–61.1 Gy) and 37.0 Gy (3.6–55.8 Gy) with a limit of 45 Gy per motor zone. Thus, the average dose of Dmean according to the maps of the motor zones of NTMs was significantly reduced by 5.3±3.3 Gy (14.3%, pDISCUSSION: In our study, it was shown that maps of the motor zones of NTMs can be used in the planning of LT patients with gliomas of high malignancy. To date, the primary motor cortex has not been considered as an OR in such patients. The results of the study demonstrated that the dose in relation to the maps of the motor zones of NTMs can be significantly reduced without affecting the therapeutic doses for PTV.CONCLUSION: LT planning using NTMs motor maps can help reduce the radiation dose to the motor cortex in primary LT, although the motor cortex appears morphologically rather insensitive to LT compared to speech zones and areas of high-order cognitive processes, such as the temporal and limbic cortex.
- Open Access
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 57-64
Baseline volumetric parameters of PET/CT 18F-FDG and international prognostic index at patients with diffuse B-cell large cell lymphoma
INTRODUCTION: Metabolic tumor volume (MTV) and Tumor lesion glycolysis (TLG) are used in 18F-fluorodeoxyglucose Positron-Emission Tomography combined with Computed Tomography (18F-FDG PET/CT) as biometric markers in whole tumor. International prognostic index (IPI) has been used during 30 years at patients with diffuse B-cell large cell lymphoma (DLBCL) for prognosis, use MTV and TLG was unknown. Our aims were to determinate the best statistical relationship between MTV, TLG and IPI in patients with DLBCL.OBJECTIVE: Complex study of baseline volumetric parameters PET/CT with 18F-FDG at patients with DLBCL and assessment of their correlation with prognostic groups.MATERIALS AND METHODS: Baseline 18F-FDG PET/CT performed in 31 primary patients with DLBCL and evaluated SUVmax, MTV, TMTV, TLG, TTLG at different involved anatomic zones; correlation between PET biomarkers and prognostic groups of patients.Statistics: The research materials were subjected to statistical processing using the methods of correlation and regression analyses.RESULTS: SUVmax mean level didn’t discerned at patients of low and high-risk groups, but TMTV has been less in favorable prognostic, than in unfavorable groups (152±3.0 sm3 vs 890±178 sm3 p3 vs 7640±2067 g/ml×sm3 , pDISCUSSION: The 30-year experience of using IPI in assessing the prognosis of patients with DLBCL has shown its insufficient effectiveness in many clinical situations, and the R-IPI prognostic model has been tested on a smaller number of patients and can only be considered additionally. We studied in detail the initial volumetric parameters of patients with DLBCL in different regions of the lesion and their relationship with the level of prognosis according to the IPI criteria. Our data on large values of volumetric parameters in the infradiaphragmatic areas and bones may be related to the worse prognosis in patients with these localizations. Further broader studies of the initial volumetric biomarkers of PET in DLBCL patients will contribute to the development of approximate boundaries of specific volumetric parameters for different tumor localizations.CONCLUSION: The results obtained showed that the baseline volumetric parameters PET/CT at patients with DLBCL have significant connection with prognostic groups of patients and can be additional factors to influence of tactics of therapy.
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 57-64
Open AccessBaseline volumetric parameters of PET/CT 18F-FDG and international prognostic index at patients with diffuse B-cell large cell lymphoma
INTRODUCTION: Metabolic tumor volume (MTV) and Tumor lesion glycolysis (TLG) are used in 18F-fluorodeoxyglucose Positron-Emission Tomography combined with Computed Tomography (18F-FDG PET/CT) as biometric markers in whole tumor. International prognostic index (IPI) has been used during 30 years at patients with diffuse B-cell large cell lymphoma (DLBCL) for prognosis, use MTV and TLG was unknown. Our aims were to determinate the best statistical relationship between MTV, TLG and IPI in patients with DLBCL.OBJECTIVE: Complex study of baseline volumetric parameters PET/CT with 18F-FDG at patients with DLBCL and assessment of their correlation with prognostic groups.MATERIALS AND METHODS: Baseline 18F-FDG PET/CT performed in 31 primary patients with DLBCL and evaluated SUVmax, MTV, TMTV, TLG, TTLG at different involved anatomic zones; correlation between PET biomarkers and prognostic groups of patients.Statistics: The research materials were subjected to statistical processing using the methods of correlation and regression analyses.RESULTS: SUVmax mean level didn’t discerned at patients of low and high-risk groups, but TMTV has been less in favorable prognostic, than in unfavorable groups (152±3.0 sm3 vs 890±178 sm3 p3 vs 7640±2067 g/ml×sm3 , pDISCUSSION: The 30-year experience of using IPI in assessing the prognosis of patients with DLBCL has shown its insufficient effectiveness in many clinical situations, and the R-IPI prognostic model has been tested on a smaller number of patients and can only be considered additionally. We studied in detail the initial volumetric parameters of patients with DLBCL in different regions of the lesion and their relationship with the level of prognosis according to the IPI criteria. Our data on large values of volumetric parameters in the infradiaphragmatic areas and bones may be related to the worse prognosis in patients with these localizations. Further broader studies of the initial volumetric biomarkers of PET in DLBCL patients will contribute to the development of approximate boundaries of specific volumetric parameters for different tumor localizations.CONCLUSION: The results obtained showed that the baseline volumetric parameters PET/CT at patients with DLBCL have significant connection with prognostic groups of patients and can be additional factors to influence of tactics of therapy.
- 12 April 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (2) , 202-210
Significance of diagnostic transcranial magnetic stimulation during radiotherapy
Background. Transcranial magnetic stimulation is a non-invasive, painless method that stimulates the cerebral cortex using short magnetic pulses. The information obtained as a result of the research can be further used for an objective assessment of the therapy. Aim. Evaluation the reliability of transcranial magnetic stimulation technique as a neurophysiological monitoring tool in patients with malignant brain tumors. Material and methods. There were two groups as a study objects: patients with large-focal solitary lesions of the central nervous system (glioma) who underwent radiotherapy (n=20), median age 49.55.3 (39; 60) years, and a comparison group of neurologically healthy individuals (n=16), median age 48.56.3 (43.0; 58.8) years. There were no statistically significant age differences between the studied groups. All patients underwent diagnostic transcranial magnetic stimulation before and after therapy. The MannWhitney test was used to make comparisons between the two groups. A p value 0.05 was considered statistically significant. Results. During transcranial magnetic stimulation in patients with malignant brain neoplasms, signs of impaired conduction along the central motor pathways were recorded in 50% of cases, and in total, signs of impaired conduction of all degrees of severity along the central motor pathway were detected in 90% of cases. Carrying out diagnostic transcranial magnetic stimulation according to a single-pulse protocol makes it possible to predict the further course of the recovery period. The use of transcranial magnetic stimulation in dynamics revealed an improvement in conduction along the central motor pathways in patients with malignant brain neoplasms. The obtained statistically significant differences allow us to conclude that transcranial magnetic stimulation can be used for an objective assessment of the state of the motor pathways in patients with neurooncological diseases. Conclusion. Diagnostic transcranial magnetic stimulation is applicable in large-focal solitary lesions of the central nervous system, since it allows assessing the state of the motor pathways and the functional activity of the brain at different stages of this condition.
- 12 April 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (2) , 202-210
Significance of diagnostic transcranial magnetic stimulation during radiotherapy
Background. Transcranial magnetic stimulation is a non-invasive, painless method that stimulates the cerebral cortex using short magnetic pulses. The information obtained as a result of the research can be further used for an objective assessment of the therapy. Aim. Evaluation the reliability of transcranial magnetic stimulation technique as a neurophysiological monitoring tool in patients with malignant brain tumors. Material and methods. There were two groups as a study objects: patients with large-focal solitary lesions of the central nervous system (glioma) who underwent radiotherapy (n=20), median age 49.55.3 (39; 60) years, and a comparison group of neurologically healthy individuals (n=16), median age 48.56.3 (43.0; 58.8) years. There were no statistically significant age differences between the studied groups. All patients underwent diagnostic transcranial magnetic stimulation before and after therapy. The MannWhitney test was used to make comparisons between the two groups. A p value 0.05 was considered statistically significant. Results. During transcranial magnetic stimulation in patients with malignant brain neoplasms, signs of impaired conduction along the central motor pathways were recorded in 50% of cases, and in total, signs of impaired conduction of all degrees of severity along the central motor pathway were detected in 90% of cases. Carrying out diagnostic transcranial magnetic stimulation according to a single-pulse protocol makes it possible to predict the further course of the recovery period. The use of transcranial magnetic stimulation in dynamics revealed an improvement in conduction along the central motor pathways in patients with malignant brain neoplasms. The obtained statistically significant differences allow us to conclude that transcranial magnetic stimulation can be used for an objective assessment of the state of the motor pathways in patients with neurooncological diseases. Conclusion. Diagnostic transcranial magnetic stimulation is applicable in large-focal solitary lesions of the central nervous system, since it allows assessing the state of the motor pathways and the functional activity of the brain at different stages of this condition.
- Open Access
- 16 March 2022
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 5 (1) , 37–45
Possibility of PET/CT in Patients’ with Extranodal Diffffuse Large B-Cell Lymphoma of Stomach at Difffferent Treatment Stages
Introduction: Gastric extranodal diffuse large B-cell lymphoma (DLBCL) is one of the most common types of lymphoma. The management of patients with DLBCL of s tomach includes immunochemotherapy, radiotherapy and surgery, but there is no standard approach. Endoscopy as a part of diagnostic workup is obligatory, but using positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) is not obligatory at different stages of observation and treatment.Purpose: To evaluate the diagnostic precision of PET/CT with 18F-FDG in both assesement and treatment stages for patients with extranodal DLBCL of stomach. Materials and methods. In this study we describe early and late therapeutic outcomes of 23 patients with primary extranodal DLBCL of stomach, treated in our center between 2010 and 2018, who received R-CHOP immunochemotherapy regimen. There were PET/CT and fibrogastroduodenoscopy (EGD) provided for all patients on every stage of assessment.Results: The diagnostic accuracy of PET/CT before the treatment was 87 %, after immunochemotherapy — 91,3 %, after radiotherapy — 100 %.Conclusions: This study shows up the role of including PET/CT scan as an observation method for patients with extranodal DLBCL of stomach on each stage of treatment and response assessment, especially for long-term prognosis evaluation.
- 16 March 2022
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 5 (1) , 37–45
Open AccessPossibility of PET/CT in Patients’ with Extranodal Diffffuse Large B-Cell Lymphoma of Stomach at Difffferent Treatment Stages
Introduction: Gastric extranodal diffuse large B-cell lymphoma (DLBCL) is one of the most common types of lymphoma. The management of patients with DLBCL of s tomach includes immunochemotherapy, radiotherapy and surgery, but there is no standard approach. Endoscopy as a part of diagnostic workup is obligatory, but using positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) is not obligatory at different stages of observation and treatment.Purpose: To evaluate the diagnostic precision of PET/CT with 18F-FDG in both assesement and treatment stages for patients with extranodal DLBCL of stomach. Materials and methods. In this study we describe early and late therapeutic outcomes of 23 patients with primary extranodal DLBCL of stomach, treated in our center between 2010 and 2018, who received R-CHOP immunochemotherapy regimen. There were PET/CT and fibrogastroduodenoscopy (EGD) provided for all patients on every stage of assessment.Results: The diagnostic accuracy of PET/CT before the treatment was 87 %, after immunochemotherapy — 91,3 %, after radiotherapy — 100 %.Conclusions: This study shows up the role of including PET/CT scan as an observation method for patients with extranodal DLBCL of stomach on each stage of treatment and response assessment, especially for long-term prognosis evaluation.